Skip to contentpdufa.bio

VAX-A1 (Group A Streptococcus vaccine)

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

VAX-A1 (Group A Streptococcus vaccine) is a Vaxcyte, Inc. program in group A Strep disease prevention. Its next catalyst is a Readout in Q4 2027.

PCVX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Indication under review: Group A Strep disease prevention. Sponsor: Vaxcyte, Inc. (PCVX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q4 2027PCVX

Specialist biotech funds holding PCVX, 13F for the quarter ended September 30, 2026

FundSharesValue at quarter endFiling
RA Capital Management11,474,599$652.9 millionfiled November 16, 2026
Cormorant Asset Management15,000$853,500filed November 16, 2026

13F reports list long positions in common stock at quarter end, are due 45 days later, and show no short positions or later trades. Notes, warrants and other instruments are not counted as shares.

Questions

When is VAX-A1 (Group A Streptococcus vaccine)'s next FDA decision or readout?

The next tracked catalyst for VAX-A1 (Group A Streptococcus vaccine) is a Readout in Q4 2027.

What happened at VAX-A1 (Group A Streptococcus vaccine)'s most recent FDA decision?

No FDA decision for VAX-A1 (Group A Streptococcus vaccine) is in our archive yet.

What is VAX-A1 (Group A Streptococcus vaccine) used for?

In our records VAX-A1 (Group A Streptococcus vaccine) is under review or in development for Group A Strep disease prevention.

Who makes VAX-A1 (Group A Streptococcus vaccine)?

Vaxcyte, Inc. (PCVX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.